Wolden, Michael

Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study

Khunti, K., Davies, M., Majeed, A., Thorsted, B. L., Wolden, M. L., & Paul, S. K. (2015) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 356

Non-severe nocturnal hypoglycemic events: Experience and impacts on patient functioning and well-being

Brod, M., Pohlman, B., Wolden, M., & Christensen, T. (2013) · Quality of Life Research

Diabetes Management and ResearchDiabetes Management and Education

Cited by 71

Improvements in health‐related quality of life with liraglutide 3.0 mg compared with placebo in weight management

Kolotkin, R. L., Fujioka, K., Wolden, M. L., Brett, J. H., & Bjorner, J. B. (2016) · Clinical Obesity

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 40

Switching to degludec from other basal insulins is associated with reduced hypoglycemia rates: A prospective study

Fadini, G. P., Feher, M., Hansen, T. K., de Valk, H. W., Koefoed, M. M., Wolden, M., Zimmermann, E., & Jendle, J. (2019) · The Journal of Clinical Endocrinology & Metabolism

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 27

Increased risk of severe hypoglycemic events with increasing frequency of non-severe hypoglycemic events in patients with type 1 and type 2 diabetes

Sreenan, S., Andersen, M., Thorsted, B. L., Wolden, M. L., & Evans, M. (2014) · Diabetes Therapy

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 21

Response to Comment on Khunti et al. Clinical Inertia in People With Type 2 Diabetes: A Retrospective Cohort Study of More Than 80,000 People. Diabetes Care 2013;36:3411–3417

Khunti, K., Wolden, M. L., Thorsted, B. L., Andersen, M., & Davies, M. J. (2014) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 3